Skip to content
Trial Eligibility
Menu

Role of Transposable Elements in Septic Immune Aging

NCT06809868

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to answer is: Do transposable elements prematurely age the immune systems of patients with sepsis? Do transposable elements correlate with increased mortality in patients with sepsis in the ICU? Do transposable elements correlate with increased amount of secondary infections in patients with sepsis in the ICU? Participants will have blood drawn from them but will not be subjected to additional interventions.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Sepsis
  • Sepsis and Septic Shock
  • Sepsis With Multiple Organ Dysfunction (MOD)
  • Sepsis With Acute Organ Dysfunction
  • Sepsis, Severe
  • Sepsis at Intensive Care Unit
  • Sepsis, Severe Sepsis and Septic Shock
  • Sepsis, Septic Shock

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
University of California, San Francisco
Last updated on ClinicalTrials.gov
January 30, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • University of California, San Francisco · San Francisco, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.